Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : All About Sun Microsystems -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (45340)	9/17/2001 2:39:13 PM
From: High-Tech East	Respond to of 64865

ABIOMED Announces First European Site for AbioCor Implantable Replacement Heart Clinical Trial Monday September 17, 12:44 pm Eastern Time, Press Release Danvers, Mass.--(BW HealthWire)--Sept. 17, 2001--ABIOMED, Inc. (NASDAQ:ABMD - news) today announced that the North Rhine-Westphalia Heart Center, Bad Oeynhausen, Germany will serve as a European clinical trial site for the AbioCor Implantable Replacement Heart. The European trial of the AbioCor is expected to begin within the next six months. "We are very pleased to have reached this agreement with North Rhine-Westphalia'' said Dr. David M. Lederman, ABIOMED's Chief Executive Officer. "It is our goal to work with the very best and most experienced heart transplant and mechanical heart assistance programs in the world in bringing the AbioCor Implantable Replacement Heart through clinical trials and into the clinical setting. The program at Bad Oeynhausen is distinguished by the quality and efficiency of its work, and by the breadth of its experience with advanced heart assist systems. We look forward to a close and mutually rewarding working relationship with Prof. Dr. med. R. Korfer and his team.'' "I'm very pleased and proud that we are now in the start-up phase for the clinical trial of the AbioCor,'' said Prof. Dr. med. Reiner Korfer, Director of the heart surgery program of the Heart Center North Rhine-Westphalia. "ABIOMED's choice of our center is for me an acknowledgement of our successful work during the past years. We are committed to the development of the replacement heart as a widely available clinical option made necessary by limitations in the availability and applicability of transplantation, and we share with ABIOMED a continuous focus on improving the quality of life of our patients.'' The Heart Center North Rhine-Westphalia, founded in l984, is the largest cardiac surgery facility in Europe, and is widely recognized as an experienced center in advanced cardiac assist systems. It has been the site of more than 50,000 open heart surgeries, more than 1,000 heart transplants, and more than 550 implantations of advanced heart assist devices. biz.yahoo.com

To: JDN who wrote (45340)	9/17/2001 10:49:23 PM
From: Sonki	Read Replies (1) \| Respond to of 64865

jdn, sunw held well today, is it orcl results or buy backs? On cnn, i saw a story of a father who was coming home on one of those flights to deliver a baby girl. He never made it. This couple had just gotten life insurance applications ...never followed thru. A baby girl was born on 9/12 and no father. How tragic ? Nothing can justify this kind of loss. I am very scared many more innocent lives will be taken before this is over.